Abstract
Although the fecal immunochemical test (FIT) has recently emerged as an effective and affordable colorectal cancer screening option, many family physician offices continue to use guaiac-based tests. The purpose of this study was to assess the use of FITs in the Iowa Research Network and to assess physicians' knowledge about FITs. A cover letter and questionnaire were faxed twice to the 291 physician members followed up by a mailing. One hundred and seven (37 %) questionnaires were returned. Participants' mean age was 55 years with 78 male responders. Fifty-two (49 %) of the physician's offices were in a nonmetro area. Fifty-one (49 %) reported using guaiac-based tests and 39 (39 %) reported using FITs. Many physicians were unsure of the answers for the FIT knowledge questions. FIT use is not widespread in Iowa Research Network physician offices, and not all physicians are aware of the type of fecal occult blood test being conducted in their office.
Similar content being viewed by others
References
U.S. Preventive Services Task Force (2008) Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 149(9):627–637
Irons GV Jr, Kirsner JB (1965) Routine chemical tests of the stool for occult blood: an evaluation. Am J Med Sci 249:247–260
Songster CL, Barrows GH, Jarrett DD (1980) Immunochemical detection of fecal occult blood—the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer. Cancer 45(5 Suppl):1099–1102
American Cancer Society. Colorectal cancer facts & figures 2011–2013. (2011) Colorectal Cancer Facts & Figures Web site. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-028323.pdf. Accessed 27 Feb 2013
Centers for Disease Control and Prevention (CDC). (2012) Screen for life: colorectal cancer, basic facts on screening, publication #99-6949. http://www.cdc.gov/cancer/colorectal/pdf/Basics_FS_Eng_color.pdf. Accessed 5 June 2012
Centers for Disease Control and Prevention (CDC). (2012) Colorectal cancer screening saves lives. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/Features/VitalSigns/CancerScreening/. Accessed 23 July 2012
Park DI, Ryu S, Kim YH et al (2010) Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 105(9):2017–2025
Birkenfeld S, Belfer RG, Chared M et al (2011) Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. J Med Screen 18(3):135–141
Wilschut JA, Hol L, Dekker E (2011) Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology 141(5):1648–1655
Allison JE, Sakoda LC, Levin TR et al (2007) Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99(19):1462–1470
Klabunde C, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW (2009) Colorectal cancer screening by primary care physicians: recommendations and practices, 2006–2007. Am J Prev Med 37(1):1–7
Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC (2010) Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations. J Gen Intern Med 25(8):833–839
Acknowledgments
The Department of Family Medicine of The University of Iowa is gratefully acknowledged. NIH RC4 CA153493.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Daly, J.M., Bay, C. & Levy, B.T. Use of Fecal Immunochemical Tests in the Iowa Research Network. J Canc Educ 28, 397–401 (2013). https://doi.org/10.1007/s13187-012-0439-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-012-0439-8